News

Fund News

• November 16, 2023

Jeremy Caldwell, Ph.D., Accomplished Biopharma Executive, Company Creator and R&D Leader, Joins Red Tree Venture Capital as Partner

Fund News

• November 16, 2023

West Coast investor Red Tree on its San Diego expansion and staying bullish in biotech

Portfolio News

• November 9, 2023

CARGO Therapeutics Announces Pricing of Initial Public Offering

Portfolio News

• April 17, 2023

Pipeline Therapeutics Announces Global License and Development Agreement for Investigational Neuroscience Therapy, PIPE-307

Portfolio News

• March 6, 2023

Bicara Therapeutics Announces Oversubscribed $108 Million Series B Financing to Advance Clinical-Stage Pipeline of Dual-Action Biologics to Treat Cancer

Portfolio News

• March 2, 2023

Ceribell Named to Fast Company’s 2023 List of the World’s Most Innovative Companies

Portfolio News

• March 1, 2023

CARGO Therapeutics Raises $200 Million in Oversubscribed, Upsized Series A Financing to Advance its Pipeline of Next Generation CAR T-Cell Therapies

Portfolio News

• March 1, 2023

Tachyon Announces Financing and Start of Clinical Study of First-in-Class KDM4 Inhibitor for Advanced Cancers

Portfolio News

• September 21, 2022

Ceribell Closes $50 Million Equity Financing Round Led by Ally Bridge Group

Portfolio News

• September 8, 2022

Ceribell Receives FDA Breakthrough Device Designation for Delirium Indication

Portfolio News

• September 6, 2022

Magnus Medical Receives FDA Clearance for the SAINT Neuromodulation System for Non-Invasive, Individualized and Precise Treatment of Severe Depression

Portfolio News

• July 7, 2022

Magnus Medical Featured on The Today Show – Magnet Therapy Brings Hope to People with Depression

Portfolio News

• June 22, 2022

Alladapt Announces Completion of Oversubscribed $119 Million Institutional Financing

Portfolio News

• March 17, 2022

Alladapt Announces Initiation of Encore Open-Label Extension Study for its Harmony Phase 1/2 Study of ADP101 for Treatment of Food Allergy

Portfolio News

• March 2, 2022

Rondo Therapeutics Closes $67 Million Series A Financing to Advance NextGeneration Immuno-Oncology Platform for Solid Tumors

Portfolio News

• September 28, 2021

Acrigen Biosciences Raises Seed Financing to Advance Precision Gene Editing Technology and Therapeutic Pipeline

Portfolio News

• February 11, 2021

Pipeline Therapeutics Completes $80 Million Series C Financing